-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Reiterates Hold on Tandem Diabetes Care, Raises Price Target to $27

Benzinga·02/23/2026 13:54:17
Listen to the news
Truist Securities analyst Richard Newitter reiterates Tandem Diabetes Care (NASDAQ:TNDM) with a Hold and raises the price target from $24 to $27.